BioSyent Releases Financial Results for Q1 2021
May 27, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2021. Key highlights...
BioSyent to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co....
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2020
March 17, 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2020. Key...
BioSyent Announces Renewal of Normal Course Issuer Bid
December 11, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Releases Financial Results for Third Quarter and First Nine Months of 2020
November 26, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 26, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2020. Key...
BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020
November 17, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Named to the Growth List Ranking of Canada’s Fastest-Growing Companies for Eighth Consecutive Year
October 15, 2020 09:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 15, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been included in the 32nd annual Growth List, the definitive...
BioSyent Annonce L'Introduction du Nouveau FeraMAX® Pd
October 05, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 05 oct. 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », « la Société », Bourse de croissance : RX) a le plaisir d’annoncer l’introduction de FeraMAX® Pd, une nouvelle...
BioSyent Announces Introduction of New FeraMAX® Pd
October 05, 2020 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 05, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the introduction of FeraMAX® Pd, a new oral iron supplement...
BioSyent Releases Q2 and H1 2020 Results
August 26, 2020 07:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 26, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30,...